Viscosupplementation Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Viscosupplementation Market Overview
The Viscosupplementation market size was valued at $1.5 billion in 2023 and is forecast to grow at a CAGR of more than 4% during 2023 and 2033. Viscosupplementation is the process by which the synovial fluid at the joints is replaced by a Hyaluronate preparation which has viscous properties like the natural synovial fluid. Viscosupplementation is used for the treatment of osteoarthritis of the knee and other joints. Other joints include the hip, shoulder, ankle, elbow, wrist, hand, and foot.
Viscosupplementation Market Outlook, 2023-2033 ($ Billion)
Buy the Full Report for More Insights into the Viscosupplementation Market Forecast
The Viscosupplementation market research report explains the market behavior, which will help identify quantitative market trends within the orthopedic devices therapeutic area. The model discusses in detail the impact of COVID-19 on the Viscosupplementation market for the year 2020 and beyond. The report has extensively covered pipeline products and technologies, which will help in identifying companies with the most robust pipeline. This, in turn, will assist in predictive analysis for designing in-licensing and out-licensing strategies.
Market Size (2022) | $1.5 Billion |
CAGR | >4% |
Forecast Period | 2023-2033 |
Historical Period | 2015-2022 |
Key Regions | · North America
· Europe · Asia Pacific · South Central America · Middle East and Africa |
Key Viscosupplementation Segments | · 3-injection
· 1-injection · 5-injection |
Leading Companies | · Sanofi
· Seikagaku Corp · Bioventus Inc · Anika Therapeutics Inc · Fidia farmaceutici SpA |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Viscosupplementation Market Dynamics
To maintain an active lifestyle, including in the aging population, individuals are seeking viscosupplementation to delay the need for a total knee replacement. The prevalence of osteoarthritis (OA) is rising and is globally driven primarily by the growing aging population and an increase in the number of obese individuals. Though there is no cure for arthritis many treatment options have been developed to improve the daily activities of the affected individuals.
Viscosupplementation Market Segments
The Viscosupplementation market primarily consists of 3-injection 1-injection, and 5-injection. 3-injection led the Viscosupplementation market in 2023.
3-injection comprises a central hollow shaft and is used in the fixation of bone and joint breaks and to secure artificial implants such as bone grafts. The hollow shaft allows the screw to advance over a guide wire (usually Kirschner (“K”) wires) or a guide pin and helps in the precise placement of the screw. One unit comprises one Cannulated Screw.
Viscosupplementation Market Analysis by Segments, 2023 (%)
Buy the Full Report for More Insights into the Segments of the Viscosupplementation Market
Viscosupplementation Market Segmentation by Regions
The key regions in the Viscosupplementation market are North America, Europe, Asia Pacific, South Central America, and the Middle East and Africa. North America led the market in 2023.
The North American market for Viscosupplementation is primarily driven by the US market. GlobalData expects an increase in the market size of Viscosupplementation in the forecast period due to the increasing aging and obese population who opt for substitute methods for knee replacement surgeries.
Viscosupplementation Market Analysis by Regions, 2023 (%)
Buy the Full Report for More Insights into the Regions leading in the Viscosupplementation Market
Viscosupplementation Market - Competitive Landscape
Some of the leading companies in the Viscosupplementation market are Sanofi, Seikagaku Corp, Bioventus Inc., Anika Therapeutics Inc., and Fidia farmaceutici SpA among others. Sanofi held the largest share of the Viscosupplementation market in 2023.
Viscosupplementation Market Analysis by Companies, 2023 (%)
Buy the Full Report for More Insights into the Companies leading in the Viscosupplementation Market
Segments Covered in the Report
Viscosupplementation Segments Outlook (Value, $ Billion, 2015-2033)
- 3-injection
- 1-injection
- 5-injection
Viscosupplementation Regional Outlook (Value, $ Billion, 2015-2033)
- North America
- Europe
- Asia Pacific
- South Central America
- Middle East and Africa
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for –
- CMO executives who must have a deep understanding of the Viscosupplementation marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base to make decisions about supplier selection and management.
- Private equity investors need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The model will enable you to –
- Understand the impact of COVID-19 on the Viscosupplementation market.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the Viscosupplementation market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Viscosupplementation market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific Viscosupplementation from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Seikagaku Corp
Bioventus Inc
Anika Therapeutics Inc
Fidia farmaceutici SpA
Ferring Pharmaceuticals AS
Zimmer Biomet Holdings Inc
Others
Frequently asked questions
-
What was the Viscosupplementation market size in 2023?
The Viscosupplementation market size was valued at $1.5 billion in 2023.
-
What will be the Viscosupplementation market growth during 2023 and 2033?
The Viscosupplementation market is forecast to grow at a CAGR of more than 4% during the forecast period.
-
Which region held the largest share of the Viscosupplementation market in 2023?
The North American market for Viscosupplementation held the largest market share in 2023.
-
Which segment held the largest share of the Viscosupplementation market in 2023?
3-injection accounted for the highest share of the Viscosupplementation market in 2023.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.